Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has reported a change in the director’s interest notice, indicating that director Peter Laurence Molloy, through an indirect interest held by Christine Louise Molloy, participated in a Share Purchase Plan resulting in the acquisition of 454,545 ordinary fully paid shares, valued at $25,000. Prior to the transaction, the indirect holdings included over 30 million shares by Aquarico Pty Ltd and 1,030,000 shares by Christine Louise Molloy, which, after the change, increased to approximately 1.48 million shares in her name.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.